Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization

Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization

Alzheimer’s disease (AD) is a neurodegenerative disorder associated with marked oxidative stress at the level of the brain. Recent studies indicate that increasing the antioxidant capacity could represent a very promising therapeutic strategy for AD treatment. Astaxanthin (AST), a powerful natural a...

Full description

Bibliographic Details
Main Authors: Debora Santonocito, Giuseppina Raciti, Agata Campisi, Giovanni Sposito, Annamaria Panico, Edy Angela Siciliano, Maria Grazia Sarpietro, Elisabetta Damiani, Carmelo Puglia
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Nanomaterials
Subjects:
astaxanthin
stealth system
SLN
Alzheimer’s disease
ORAC
parenteral administration
Online Access:https://www.mdpi.com/2079-4991/11/2/391

Internet

https://www.mdpi.com/2079-4991/11/2/391

Similar Items